Professionals 52 results
Capabilities 20 results
Industry
Industry
Practice Area
Financial Services Transactions & Regulatory
Experience 2 results
Experience
|July 25, 2022
GloriFi Announces Business Combination with DHC Acquisition Corp.
Experience
|April 30, 2016
Insights & News 159 results
Client Alert
|May 17, 2024
|6 Min Read
A unique entity, the Consumer Financial Protection Bureau (CFPB) has faced court challenges to its policies and structure since its inception. But in recent years, as the CFPB has become more active and, arguably, more aggressive, it has faced increasing legal scrutiny. The swirling legal challenges against the CFPB raise questions for banks and other regulated entities regarding not only how to respond to CFPB’s rulemaking but how quickly they should act to do so. This article addresses the main litigation surrounding credit card late fees and its overlap with the recent Supreme Court case upholding the validity of the Bureau’s funding structure, and in this context provides further insight into the pace at which an entity should respond to this quasi-regulator/quasi-enforcer.
Capital Markets & Securities Law Watch
|April 30, 2024
|6 Min Read
SEC Targets “AI Washing” by Companies, Investment Advisers, and Broker-Dealers
With consumer and investor interest in artificial intelligence (AI) surging, there has been heightened concern among regulatory agencies, including the Federal Trade Commission (FTC) and the Securities and Exchange Commission (SEC), with companies engaging in a deceptive practice the FTC and SEC have dubbed “AI washing.”
Government Program Fraud, False Claims Act & Qui Tam Litigation Playbook
|April 17, 2024
|9 Min Read
E.D. Virginia Endorses Broad Interpretation of Anti-Kickback Statute
The U.S. District Court for the Eastern District of Virginia is the latest court to weigh in on the continuing debate surrounding the scope of the Federal Anti-Kickback Statute (AKS) as it applies to patient assistance programs (PAPs). In a lengthy opinion issued in January 2024, the court endorsed the broad interpretation advanced by the government, expressing little sympathy for the legal or policy arguments advanced by the plaintiffs, a coalition of pharmaceutical manufacturers. The coalition has indicated it will appeal the case to the Fourth Circuit.
Other Results 15 results
Law Glossary
Law Glossary
What Is Financial Privacy Law?
Law Glossary